DataMeds AI: Hyperscale reports 9.99% ownership
The reported position assumes note conversion at the initial floor price of $1.00 per share and excludes additional note and warrant shares subject to ownership blockers.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
DataMeds AI, Inc. common stock is the subject of Hyperscale Data, Inc.’s report of beneficial ownership of 501,204 shares, or 9.99% of the class. Hyperscale reported shared voting and dispositive power over the shares, which are issuable upon conversion of a convertible promissory note held by Ault Lending, LLC. The reported calculation assumes conversion at the initial floor price of $1.00 per share. It excludes 123,796 additional shares issuable under the note due to a 9.99% beneficial ownership blocker and 245,419 shares issuable upon warrant exercise due to a 4.99% blocker. DataMeds AI had 4,515,862 shares issued and outstanding as of August 18, 2026.
Key Figures
Key Terms
convertible promissory note financial
beneficial ownership blocker financial
initial floor price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.